Cardiac Angiosarcoma Global Registry
Part of Cancer clinical trials.
This study is a global registry for people with a rare heart cancer called cardiac angiosarcoma. It collects information on treatments and outcomes to help doctors better understand the disease and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of cardiac angiosarcoma (a rare heart cancer) or a related subtype.
- Your diagnosis must have happened between January 2015 and January 2035.
- You are willing to give your permission (informed consent) to join the study.
- You agree to share your medical records and be available for follow-up.
- You can have had any type of treatment (surgery, chemo, radiation, or immunotherapy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients with angiosarcoma that has not spread and can be removed with surgery. The goal is to learn more about how this rare cancer behaves and how it is best treated.
This study is a German “registry,” meaning it collects information about people with specific bone or soft tissue tumors (including some borderline or hard-to-classify cases). It helps doctors and researchers learn more about these rare conditions to improve future care.
This study looks at people with different types of heart tumors to better understand their risks and outcomes. It aims to improve how doctors predict and manage future health events.
This is a registry (a research database) for people who are being followed in cardio-oncology, which means care for heart problems related to cancer or cancer treatments. It may help doctors better understand these conditions and improve future care.
This study collects information from patients with neuroendocrine tumors that affect the heart. It aims to better understand and treat this rare condition by gathering data from routine tests and procedures.
This study is a “registry,” meaning it collects health information from adults who are getting a new heart (cardio) evaluation related to cancer. It helps doctors better understand heart risks and care needs for different cancer types and treatments.
Hear when a new Cardiac Angiosarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.